Vericel Posts Record Growth in 2Q19 on New Surgeons


Full year revenue guidance raised to $112MM to $116MM, an increase of $2MM on both the high and low ends
Growth driven by growing surgeon base and increased utilization
Vericel has increased the estimated total MACI surgeon base from 3,000 to 5,000
Leadership estimates that MACI has penetrated about 5% of the target...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us